Clinical collection and protein properties of expressed prostatic secretions as a source for biomarkers of prostatic disease
about
iTRAQ identification of candidate serum biomarkers associated with metastatic progression of human prostate cancerIn-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urineUrinary proteomics and metabolomics studies to monitor bladder health and urological diseasesProstate cancer proteomics: Current trends and future perspectives for biomarker discovery.Investigation of the ovarian and prostate cancer peptidome for candidate early detection markers using a novel nanoparticle biomarker capture technology.In-depth proteomic analyses of direct expressed prostatic secretions.The application of SELDI-TOF-MS in clinical diagnosis of cancersProteomics in prostate cancer biomarker discovery.Identification of genital tract markers in the human seminal plasma using an integrative genomics approach.Analysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: an update for 2009-2010.The C-terminal fragment of prostate-specific antigen, a 2331 Da peptide, as a new urinary pathognomonic biomarker candidate for diagnosing prostate cancer.Advances in urinary protein biomarkers for urogenital and non-urogenital pathologies.Glycoprotein fucosylation is increased in seminal plasma of subfertile men.Identification of differentially expressed proteins in direct expressed prostatic secretions of men with organ-confined versus extracapsular prostate cancer.Dysregulated expression of cell surface glycoprotein CDCP1 in prostate cancerIdentification of prostate-enriched proteins by in-depth proteomic analyses of expressed prostatic secretions in urine.The present and future of prostate cancer urine biomarkers.Targeted proteomics identifies liquid-biopsy signatures for extracapsular prostate cancer.miR-888 is an expressed prostatic secretions-derived microRNA that promotes prostate cell growth and migration.Increased bisecting N-acetylglucosamine and decreased branched chain glycans of N-linked glycoproteins in expressed prostatic secretions associated with prostate cancer progression.Application of proteomic technologies for prostate cancer detection, prognosis, and tailored therapy.Seminal plasma glycoproteins in male infertility and prostate diseases: is there a chance for glyco-biomarkers?Seminal plasma as a diagnostic fluid for male reproductive system disorders.Identification of prostate cancer biomarkers in urinary exosomes.Detection of prostate cancer using a voltammetric electronic tongue.The use of selected ion flow tube mass spectrometry to detect and quantify polyamines in headspace gas and oral air.Alterations in expressed prostate secretion-urine PSA N-glycosylation discriminate prostate cancer from benign prostate hyperplasia.Discovery of Antimicrobial Peptides in Cervical-Vaginal Fluid from Healthy Nonpregnant Women via an Integrated Proteome and Peptidome Analysis.The enigmatic seminal plasma: a proteomics insight from ejaculation to fertilization.Q57130729Ultrasensitive aptamer-based SERS detection of PSAs by heterogeneous satellite nanoassembliesTowards the potential use of 1H NMR spectroscopy in urine samples for prostate cancer detection
P2860
Q21134794-2CF6EF3E-CE8F-499F-8D5C-89A88AE52906Q24337415-BA3AE287-5D14-4A54-9E0D-1441C0409C09Q26752864-55F27ABD-67EC-495B-B1B3-7BBAAEFCFF67Q33567004-4C974F01-BD52-4C6C-A0EB-FCB0C235506FQ33605010-FB5F3651-BBE0-42F1-97C6-D45068CA951CQ33849273-D6E91571-BA2A-405C-AD5A-7AD279627CC4Q33936575-A71A35F8-52D6-42DE-9C5A-0FCFB470E584Q34096086-E37A7B8B-853A-40DA-B8DD-A8BA8434A336Q34424875-3238A823-6685-416B-A8F0-DEF64A27DEF6Q35174495-AA5BD684-F473-46B1-B4FB-55919EFE1AC2Q35261674-51D74E9C-BB19-44A2-9958-D10AD6C617C4Q35460015-C53CC88B-2075-4768-A448-81559BFE916EQ36293042-790DD7F8-E5BA-4CEA-90E9-FC4A335423A9Q36455680-263991BD-E90B-443C-99A5-3D40DB134063Q36685495-30FF9EDC-3B1B-4EAE-B22D-63B3D3272A33Q36811800-F3154CE8-6C31-45E3-8CA4-F5F6BF7FB8A9Q37007392-776B906A-4B48-4C1C-B93E-FFA954BC6C62Q37060938-073CE956-989C-4522-A74F-7E3C39700EBAQ37529983-E6D85426-4066-476B-A550-B744758EEEADQ37672628-BE1143AD-B1F7-4820-8864-E5FE07A4450DQ37790704-AA763420-29E9-4B99-84A7-DD73FA0CB87EQ38051694-B01CC58C-C5FE-4731-8CE9-006B1021D73FQ38202841-C4BEB66E-7B6C-4C6E-92C8-B458B0A74449Q38286457-080EB189-8A03-4244-835D-5C199A0FAE11Q39634745-AFD218E5-1799-44EE-8E04-907F25ABF8A7Q43240670-544DC02F-82A2-4955-98E1-0B0C920D97EDQ47098249-491A3690-7A4A-45C6-8B00-A3F0D97AC57BQ47630183-DDF80478-268E-45F3-AEA4-FA34021365C7Q54966167-C060C2A4-137C-4AFA-BEC5-B992ACC63F73Q57130729-9DB34575-3929-4BF1-814E-1BA5A19EED56Q57162845-35B235AF-A39E-4408-9DE3-50B093056518Q57401126-C0923F1A-C7A0-4516-8B20-98E4A4A32C27
P2860
Clinical collection and protein properties of expressed prostatic secretions as a source for biomarkers of prostatic disease
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
name
Clinical collection and protei ...... iomarkers of prostatic disease
@ast
Clinical collection and protei ...... iomarkers of prostatic disease
@en
type
label
Clinical collection and protei ...... iomarkers of prostatic disease
@ast
Clinical collection and protei ...... iomarkers of prostatic disease
@en
prefLabel
Clinical collection and protei ...... iomarkers of prostatic disease
@ast
Clinical collection and protei ...... iomarkers of prostatic disease
@en
P2093
P2860
P1476
Clinical collection and protei ...... iomarkers of prostatic disease
@en
P2093
Elena Igwe
Julius O Nyalwidhe
Krista Y White
Mary Ann Clements
O John Semmes
Raymond S Lance
Richard R Drake
Robert W Given
Thomas W Fuller
P2860
P304
P356
10.1016/J.JPROT.2009.01.007
P577
2009-01-20T00:00:00Z